Moving Towards a Universal Vaccine Against Pneumonia and Meningitis, Pg II

Key Highlights:

• Scientists are developing a universal vaccine against pneumococcal diseases caused by the bacterium Streptococcus pneumoniae, which has over a hundred different forms or serotypes.
• Current vaccines, such as Pneumovax 23 and pneumococcal conjugate vaccines (PCVs) like PCV10 and PCV14, protect against only a subset of these serotypes.
• A team of British scientists utilized reverse vaccinology to identify protein targets for a new vaccine approach.
• They developed an experimental protein-based vaccine, ZPY-CpG-Ch, which demonstrated significant protection against lethal doses of S. pneumoniae in laboratory mice.

Vaccine.jpg

Detailed Insights:

• Streptococcus pneumoniae can cause severe infections like pneumonia, meningitis, and sepsis, particularly when the immune system is weakened.
• Existing PCVs target specific capsular polysaccharides, but this can lead to the emergence of non-vaccine serotypes and increased antibiotic resistance.
• Reverse vaccinology is a modern vaccine development technique that uses computational analysis of a pathogen's genome to identify potential vaccine targets, bypassing traditional culture methods.
• The research team identified three surface proteins—zinc metalloprotease B (Z), pneumococcal adherence virulence factor A (P), and YfhO-like (Y)—as promising candidates for a universal vaccine.
• The experimental vaccine ZPY-CpG-Ch combines these proteins with immune response boosters, a synthetic DNA piece called CpG and a sugary polymer called chitosan.
• While ZPY-CpG-Ch protected mice from disease, it did not reduce the bacterial load in their upper respiratory passages, suggesting vaccinated individuals might still spread the infection.
• This research is considered a crucial initial step towards a universal vaccine that could offer broad protection against all S. pneumoniae serotypes and combat antibiotic resistance.
• Pneumococcal Conjugate Vaccines are included in India's Universal Immunisation Program to reduce mortality and morbidity in children.

Scientific/Technical Concepts Involved:

• Serotype: A distinct variation within a species of bacteria or virus, identified by its unique surface antigens.
• Capsular Polysaccharide: A sugary substance forming the outer layer of some bacteria, often used as an antigen in traditional vaccines.
• Reverse Vaccinology: A vaccine development method that uses bioinformatics to analyze pathogen genomes and identify potential vaccine targets.
• Pneumococcal Conjugate Vaccines (PCVs): Vaccines where bacterial polysaccharides are chemically linked to a carrier protein to enhance the immune response, especially in infants.